About
Trent Marx is Founder, Chairman and CEO of MyEngene Inc., a pharmacogenomics technology company preventing adverse drug reactions, the 4th leading cause of death in North America. Every four minutes, someone dies from a properly prescribed medication. MyEngene is building the solution. The company's two platforms, PGxME for comprehensive pharmacogenomic testing and PGxIQ for AI-powered real-time pharmacovigilance, work together to ensure the right drug, at the right dose, reaches the right patient. No genetic test is required for PGxIQ, making it immediately deployable across any pharmacy or health system. The company's proprietary AI validation architecture is protected by seven filed patents with eight additional vertical applications in progress.
Mr. Marx brings 35 years of experience building technology platforms across healthcare, energy, and enterprise software, with deep expertise in product strategy, AI, and taking complex technology from concept to commercial deployment.